Clinical Trial Update: BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

View source ↗

Summary

This completed observational trial evaluates adherence to Betaferon (interferon beta-1b) in patients with relapsing-remitting or secondary-progressive multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Relapsing Remitting MS (RRMS), Secondary Progressive MS (SPMS) | Status: COMPLETED